Driving commercial success in the pharmaceutical and biotech sectors demands unparalleled insight and strategic foresight.
Prognos Health empowers your commercial analytics teams by transforming the most intricate health data into actionable intelligence, fueling market growth, optimizing resource allocation, and enhancing patient engagement.
We achieve this by building upon the industry's largest and most harmonized real-world data platform, offering data on the Datavant token, and enabling the seamless integration of your existing lab data, all upheld by our high standards for compliance and data governance.
Commercial analytics teams often grapple with a fragmented and complex data ecosystem. The promise of real-world data is immense, but significant hurdles prevent its full realization:
Health data is spread across numerous sources, including lab results, Rx claims, and medical claims, making a unified patient view challenging.
Inconsistent formats, varied coding (e.g., ICD, LOINC), and diverse reporting methods across data providers create significant integration and harmonization challenges.
Critical details are often embedded in free-text notes, requiring advanced interpretation to become usable.
Gaps in patient demographics or provider information can limit the scope and precision of analyses.
Turning raw, multi-sourced data into ready-to-use, high-quality datasets for immediate analysis is a common bottleneck.
Relying on traditional consulting engagements for data integration and analysis often leads to significant expenditures and extended timelines, hindering agility.
Prognos Health offers a robust platform and services designed to
empower commercial analytics teams, enabling deeper insights and more
effective strategies:
Our platform uniquely houses harmonized lab test results from trusted sources integrated with large sources of Rx and medical claims, providing a broad view of the patient and customer. With over 45 billion health records for 325 million de-identified patients (and 320M+ patients), our data covers 50+ therapy areas, including oncology and rare diseases.
We simplify the steps required to have ready-to-use, high-quality datasets. Our proprietary technology, including ML/AI models and over 500,000 rules and algorithms, transforms raw data into actionable insights. This involves:
Consolidating schemas, tokenizing data, and deduplicating patient records.
Standardizing units, terminology, and medical coding (ICD, LOINC) across diverse sources.
Extracting crucial medical concepts from free text, clinically interpreting results, and linking patients to treating HCPs with high attribution rates.
Prognos accelerates time to value, providing analytics-ready data that is more relevant to your unique needs.
We offer flexible delivery cadences including daily, twice-weekly, early weekly, monthly, and one-time deliveries, allowing for rapid turnaround and timely interventions.
We can also integrate existing data that clients already have directly contracted.
Engage the right HCPs and patients with targeted messaging based on deep clinical and behavioral insights.
Build sophisticated HCP segmentation tactics, understand testing and patient profiles, and align promotional efforts to drive brand awareness and acquisition.
Receive timely alerts based on patient events of interest, enabling real-time precision marketing and informing next best actions for field teams.
Map the patient journey by combining lab and claims data to understand diagnostic patterns, treatment initiation, continuation, and switches.
Leverage deep genomic data to identify and reach rare and ultra-rare patient populations.
Optimize digital display advertising campaigns by targeting HCPs managing specific patient events of interest, improving the precision and effectiveness of your media spend.
Want to see how Prognos Health collaborated with a top pharmaceutical company to accelerate their oncology drug launch from pre- to post-launch?
A pharmaceutical company launching a new cancer therapy needed to acquire, analyze, and apply patient and physician data rapidly to confirm segment hypotheses and bolster product launch and commercialization.
Prognos Health partnered with the pharmaceutical company to create a complete omnichannel program. We delivered integrated data and analytics services that supported both pre- and post-launch processes and tactics, targeting both patients and physicians.
By leveraging Prognos's capabilities, the pharmaceutical company achieved therapy-related insights and learnings in nine months that would have taken them 12 to 18 months to achieve independently.
This significantly accelerated their market penetration and commercial success.
Maximize the efficiency of sales and marketing efforts by precisely identifying the highest-potential physicians and patient populations.
Drive higher returns on your commercial investments through precise targeting and actionable intelligence.
Quickly transform raw data into ready-to-use insights, enabling faster decision-making and campaign execution.
Reduce manual data processing and integration efforts, allowing your analytics teams to focus on strategic analysis.
Respond faster to market shifts and competitor actions with timely and comprehensive data.
“Prognos data is the most consistent we are seeing across all of our data vendors and overall, the program is running very smoothly. We love to see how effectiveness changes over time from the VGCC test results and we cannot see that from other vendors.”
Rare Disease Pharma
Brand Marketing
“The Prognos Alerts program is, without doubt, the most impactful marketing lever that we can pull. It's better than any marketing campaign, segmentation, call plan, account strategy that we have used.”
Mid-tier Pharma
Brand Marketing
“We were thrilled with the new data and the additional 2,150 NPIs what were not in our current tables. This was a much bigger increase than we expected.”
Rare Disease Pharma
Marketing Director
“I must say that I am impressed with the cleanliness of the data, which columns are for numeric and non-numeric
results and the consistent units of measurement. I look forward to working with this data and aggregating it into our current deliverable.”
Top 10 Pharma
Commercial Analytics Director
Ready to elevate your commercial analytics capabilities and drive superior market performance?
Contact us today to learn how Prognos Health data can empower your team.